Seeing Is Believing

Currently out of the existing stock ratings of Michael Jungling, 5 are a HOLD (27.78%), 9 are a BUY (50%), 4 are a SELL (22.22%).
Analyst Michael Jungling, carries an average stock price target met ratio of 28% that have a potential upside of 12.26% achieved within 174 days. Previously, Michael Jungling worked at MORGAN STANLEY.
Michael Jungling’s has documented 37 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on FMS, Fresenius Medical Care at 23-Sep-2021.
Analyst best performing recommendations are on SNN (SMITH & NEPHEW SNATS).
The best stock recommendation documented was for PHG (KONINKLIJKE PHILIPS NV ADR) at 4/22/2020. The price target of $48.84 was fulfilled within 278 days with a profit of $13.23 (37.15%) receiving and performance score of 1.34.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
7 months 16 days ago
(11-Mar-2025)
0/3 (0%)
$-10.44 (-43.85%)
Hold
$27
$-9.59 (-26.21%)
$32
8 months 2 days ago
(25-Feb-2025)
3/5 (60%)
$-1.22 (-4.32%)
656
Buy
$15.29
$-21.3 (-58.21%)
$15.07
1 years 11 months 25 days ago
(02-Nov-2023)
7/14 (50%)
$-7.54 (-33.03%)
673
Buy
$33
$-3.59 (-9.81%)
$39.5
2 years 24 days ago
(03-Oct-2023)
1/2 (50%)
$10.75 (48.31%)
671
Buy
$16.94
$-19.65 (-53.70%)
$14.12
2 years 6 months 17 days ago
(10-Apr-2023)
0/3 (0%)
$-10.46 (-38.18%)
What Year was the first public recommendation made by Michael Jungling?